Acute promyelocytic leukemia: Cellular and molecular basis of differentiation and apoptosis
- 1 October 1997
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 76 (1-3), 141-149
- https://doi.org/10.1016/s0163-7258(97)00090-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- JEM-1, a novel gene encoding a leucine-zipper nuclear factor upregulated during retinoid-induced maturation of NB4 promyelocytic leukaemiaOncogene, 1997
- In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteinsBlood, 1996
- A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias.The EMBO Journal, 1996
- Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemiaGenes, Chromosomes and Cancer, 1996
- Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell linesBlood, 1994
- The POZ domain: a conserved protein-protein interaction motif.Genes & Development, 1994
- Molecular analysis of simple variant translocations in acute promyelocytic leukemiaGenes, Chromosomes and Cancer, 1994
- A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoproteinCell, 1994
- The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cellsCell, 1993
- Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.Journal of Clinical Investigation, 1993